New bone graft combo aims to halt hip collapse in early osteonecrosis
NCT ID NCT05706909
First seen Apr 22, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This study tests whether a special bone graft substitute (Genex) combined with a hip procedure and bone marrow cells can help people with early-stage osteonecrosis (bone death) of the hip. About 22 adults will receive the treatment and be followed with X-rays and MRIs to see if bone heals and the hip doesn't collapse. The goal is to control the disease and avoid or delay hip replacement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.